Molecule
Molecule is pioneering the future of biotech by leveraging blockchain technology to democratise drug development. Their platform connects researchers, investors, and patients, enabling the funding and licensing of intellectual property in an open and transparent marketplace.
Founders
I am the co-founder and Chief Executive Officer at Molecule AG, a platform to facilitate decentralized, modular, and collaborative drug development. I also co-initiated VitaDAO, PsyDAO, and bio.xyz. I previously completed an IRTA Fellowship at the National Institute on Aging (NIH/NIA/IRP) in the Laboratory of Molecular Gerontology under Dr. David M. Wilson III and Dr. Vilhelm Bohr where my work focused on DNA damage and repair. Additionally, I worked in the laboratory of Dr. Robert Fine at Columbia University investigating mechanisms of chemotherapy resistance in pancreatic cancer and working to develop novel therapeutic strategies for various cancers. The current focus of my work is decentralized science. I've developed novel organizational structures for biotech (BioDAOs) and novel funding primitives (IP-NFTs and IPTs) for translational science.